Xi'An Yufan Biotechnology Co.,Ltd Report issue

Government Phase 1

Organization Overview

First Clinical Trial
2019
NCT04037566
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Xi'An Yufan Biotechnology Co.,Ltd | Zhuhai Yufan Biotechnologies Co., Ltd